---
layout: page
title: MPEP Patent Appilcation Manual
image:
  feature: /wide/transmission-patent-gray-blueprint.jpg
---
   <head>
      <title>2426-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2400.html"><span>Chapter 2400</span></a></li>
      <li><span>Section 2426</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e246991">
                     <h1 class="page-title">2426
                        &nbsp;&nbsp;
                        Amendments to or Replacement of Sequence Listing and Computer
                        Readable Copy Thereof  [R-08.2012]
                     </h1>
                     <div id="d0e246995" class="CFR">
                        <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.825 &nbsp;
                              
                              
                              
                              Amendments to or replacement of sequence listing and computer
                              readable copy thereof.</i></h4>
                        <ul style="list-style-type: none;">
                           <li id="d0e247000" class="nobull">(a) Any amendment to a paper
                              copy of the “Sequence Listing” (§ <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(c)</a></b>)
                              must be made by the submission of substitute sheets and include a statement
                              that the substitute sheets include no new matter. Any amendment to a compact
                              disc copy of the “Sequence Listing” (§ <b><a href="mpep-9020-appx-r.html#d0e333653">1.821(c)</a></b>)
                              must be made by the submission of a replacement compact disc (2 copies) in
                              compliance with §&nbsp;<b><a href="mpep-9020-appx-r.html#d0e318327">1.52(e)</a></b>. Amendments must
                              also be accompanied by a statement that indicates support for the amendment in
                              the application, as filed, and a statement that the replacement compact disc
                              includes no new matter.
                           </li>
                           <li id="d0e247013" class="nobull">(b) Any amendment to the paper
                              copy of the “Sequence Listing,” in accordance with paragraph (a) of this
                              section, must be accompanied by a substitute copy of the computer readable form
                              (<b><a href="mpep-9020-appx-r.html#d0e333653">§ 1.821</a></b>(e)) including all
                              previously submitted data with the amendment incorporated therein, accompanied
                              by a statement that the copy in computer readable form is the same as the
                              substitute copy of the “Sequence Listing.”
                           </li>
                           <li id="d0e247020" class="nobull">(c) Any appropriate amendments
                              to the “Sequence Listing” in a patent; <i>e.g.</i>, by reason of reissue or certificate of correction, must comply
                              with the requirements of paragraphs (a) and (b) of this
                              section.
                           </li>
                           <li id="d0e247027" class="nobull">(d) If, upon receipt, the
                              computer readable form is found to be damaged or unreadable, applicant must
                              provide, within such time as set by the Commissioner, a substitute copy of the
                              data in computer readable form accompanied by a statement that the substitute
                              data is identical to that originally filed.
                           </li>
                        </ul>
                     </div>
                     <p id="d0e247031"><b><a href="mpep-9020-appx-r.html#d0e334511">37 CFR
                              1.825</a></b> sets forth the procedures for amending the “Sequence Listing”
                        and the computer readable copy thereof. The procedures that have been defined in
                        <b><a href="mpep-9020-appx-r.html#d0e334511">37
                              CFR 1.825</a></b> involve the submission of either substitute sheets or
                        substitute compact discs of the “Sequence Listing” or substitute copies of the computer
                        readable form, in conjunction with statements that indicate support for the amendment in
                        the application, as filed, and that the substitute sheets or copies include no new matter.
                        (See <b><a href="s608.html#d0e50993">MPEP §
                              608.05</a></b> and <b><a href="s2428.html#d0e247518">§&nbsp;2428 </a></b>for further
                        information.) An amendment to the material on a compact disc must be done by submitting a
                        replacement compact disc with the amended file(s). The amendment should include a
                        corresponding amendment to the description of the compact disc and the files contained
                        thereon in the paper portion of the specification. <b id="d0e247044"><i>A replacement compact disc containing the amended files also
                              must contain all of the files of the original compact disc that were not
                              amended.</i></b> This will insure that the Office, printer, and public can quickly access all of the
                        current files in an application or patent by referencing only the latest compact disc.The
                        requirement for statements regarding the absence of new matter follows current practice
                        relating to the submission of substitute specifications, as set forth in <b><a href="mpep-9020-appx-r.html#d0e323278">37 CFR
                              1.125</a></b>. <b><a href="mpep-9020-appx-r.html#d0e334511">37 CFR 1.825(c)</a></b> addresses the situation
                        where amendments to the “Sequence Listing” are made after a patent has been granted, e.g.,
                        by a certificate of correction, reissue or reexamination. <b><a href="mpep-9020-appx-r.html#d0e334511">37 CFR
                              1.825(d)</a></b> addresses the possibility and presents a remedy for the
                        situation where the computer readable form may be found by the Office to be damaged or
                        unreadable.
                     </p>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2401.html">2401-Introduction</a></li>
               <li xmlns=""><a href="s2402.html">2402-The Deposit Rules</a></li>
               <li xmlns=""><a href="s2403.html">2403-Deposit of Biological Material</a><ul>
                     <li><a href="s2403.html#d0e240728">2403.01-Material Capable of Self- Replication</a></li>
                     <li><a href="s2403.html#d0e240735">2403.02-Plant Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2404.html">2404-Need or Opportunity to Make a Deposit</a><ul>
                     <li><a href="s2404.html#d0e240816">2404.01-Biological Material That Is Known and Readily Available to the Public</a></li>
                     <li><a href="s2404.html#d0e240930">2404.02-Biological Material That Can Be Made or Isolated Without Undue Experimentation</a></li>
                     <li><a href="s2404.html#d0e240946">2404.03-Reference to a Deposit in the Specification</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2405.html">2405-Acceptable Depository</a></li>
               <li xmlns=""><a href="s2406.html">2406-Time of Making an Original Deposit</a><ul>
                     <li><a href="s2406.html#d0e241742">2406.01-Description in Application Specification</a></li>
                     <li><a href="s2406.html#d0e241769">2406.02-Deposit After Filing Date - Corroboration</a></li>
                     <li><a href="s2406.html#d0e241779">2406.03-Possible Loss of U.S. Filing Date in Other Countries</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2407.html">2407-Replacement or Supplement of Deposit</a><ul>
                     <li><a href="s2407.html#d0e241898">2407.01-In a Pending Application</a></li>
                     <li><a href="s2407.html#d0e241922">2407.02-After a Patent Has Issued</a></li>
                     <li><a href="s2407.html#d0e241949">2407.03-Failure to Replace</a></li>
                     <li><a href="s2407.html#d0e241964">2407.04-Treatment of Replacement</a></li>
                     <li><a href="s2407.html#d0e241982">2407.05-Exemption From Replacement</a></li>
                     <li><a href="s2407.html#d0e241992">2407.06-Replacement May Not Be Recognized</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2408.html">2408-Term of Deposit</a></li>
               <li xmlns=""><a href="s2409.html">2409-Viability of Deposit</a></li>
               <li xmlns=""><a href="s2410.html">2410-Furnishing of Samples</a><ul>
                     <li><a href="s2410.html#d0e242157">2410.01-Conditions of Deposit</a></li>
                     <li><a href="s2410.html#d0e242206">2410.02-Certification of Statement of Availability of Deposit</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2411.html">2411-Examination Procedures</a><ul>
                     <li><a href="s2411.html#d0e242312">2411.01-Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242401">2411.02-Replies to Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242424">2411.03-Application in Condition for Allowance Except for Deposit</a></li>
                     <li><a href="s2411.html#d0e242459">2411.04-After a Patent Has Been Granted</a></li>
                     <li><a href="s2411.html#d0e242505">2411.05-Content of Application with Respect to Deposited Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2412-2419.html">2412-2419-[Reserved]</a></li>
               <li xmlns=""><a href="s2420.html">2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence
                     Rules</a></li>
               <li xmlns=""><a href="s2421.html">2421-Overview of the Sequence Rules</a><ul>
                     <li><a href="s2421.html#d0e242552">2421.01-Applications Affected</a></li>
                     <li><a href="s2421.html#d0e242568">2421.02-Summary of the Requirements of the Sequence Rules</a></li>
                     <li><a href="s2421.html#d0e242594">2421.03-Notification of a Failure to Comply</a></li>
                     <li><a href="s2421.html#d0e242622">2421.04-Future Changes to the Sequence Rules</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2422.html">2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications</a><ul>
                     <li><a href="s2422.html#d0e245121">2422.01-Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules</a></li>
                     <li><a href="s2422.html#d0e245175">2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures</a></li>
                     <li><a href="s2422.html#d0e245191">2422.03-The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented
                           Sequence</a></li>
                     <li><a href="s2422.html#d0e245299">2422.04-The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245330">2422.05-Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer
                           of Computer Readable Form</a></li>
                     <li><a href="s2422.html#d0e245358">2422.06-Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245376">2422.07-Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply</a></li>
                     <li><a href="s2422.html#d0e245454">2422.08-Presumptions Regarding Compliance</a></li>
                     <li><a href="s2422.html#d0e245470">2422.09-Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2423.html">2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data</a><ul>
                     <li><a href="s2423.html#d0e245579">2423.01-Format and Symbols To Be Used in Sequence Listings</a></li>
                     <li><a href="s2423.html#d0e245618">2423.02-Depiction of Coding Regions</a></li>
                     <li><a href="s2423.html#d0e245637">2423.03-Presentation and Enumeration of Sequences</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2424.html">2424-Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers</a><ul>
                     <li><a href="s2424.html#d0e246252">2424.01-Informational Requirements for the Sequence Listing</a></li>
                     <li><a href="s2424.html#d0e246289">2424.02-Sequence Listing Numeric Identifiers</a></li>
                     <li><a href="s2424.html#d0e246838">2424.03-Additional Miscellaneous Requirements</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2425.html">2425-Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form</a></li>
               <li xmlns=""><a href="s2426.html">2426-Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof</a></li>
               <li xmlns=""><a href="s2427.html">2427-Form Paragraphs and Notice to Comply</a><ul>
                     <li><a href="s2427.html#d0e247062">2427.01-Form Paragraphs</a></li>
                     <li><a href="s2427.html#d0e247506">2427.02-Notice To Comply</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2428.html">2428-Sample Statements</a></li>
               <li xmlns=""><a href="s2429.html">2429-Helpful Hints for Compliance</a></li>
               <li xmlns=""><a href="s2430.html">2430-PatentIn Information; Utilities Programs; Training</a></li>
               <li xmlns=""><a href="s2431.html">2431-Sample Sequence Listing</a></li>
               <li xmlns=""><a href="s2432-2433.html">2432-2433-[Reserved]</a></li>
               <li xmlns=""><a href="s2434.html">2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences</a></li>
               <li xmlns=""><a href="s2435.html">2435-Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:34 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>